Procedure of the Ministry of Finance in fixing the maximum price of Visudyne
June 4, 2008
Procedure of the Ministry of Finance in fixing the maximum price of Visudyne
In association with inquiring into an individual complaint pertaining to the amount of patients’ supplementary payment for Visudyne (a medicine), the Defender’s deputy was informed that Visudyne is supplied by Novartis to the Czech Republic for a higher price than in other EU member states (except Slovakia). Given these facts, the deputy decided to open an inquiry on her own initiative to ascertain whether the pricing decision of the Ministry of Finance in the case of Visudyne was issued in accordance with valid legislation.